李尚-2018级-硕士

• 母校：中国药科大学
• 时间：2018.9-2021.6
• 2020.6转博
  

Shang Li, Lailiang Qu, Xiaobing Wang*, Lingyi Kong*, Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment, Pharmacology & Therapeutics,  2022, 231, 107979, DOI: 10.1016/j.pharmthera.2021.107979. IF: 13.400. 

 LI Shang, WANG Xiaobing. 

Design and synthesis of antiviral pseudo-natural products via effective one-step acylmethylation macrocyclization 

Chinese Journal of Natural Medicine, 2023, 21(0): 1-2.

DOI: 10.1016/S1875-5364(23)60440-6